• No results found

drug therapies

Potential drug therapies for the treatment of fibromyalgia

Potential drug therapies for the treatment of fibromyalgia

... potential drug therapies. Table 1 lists potential drug therapies with specified mechanisms of action exhibiting potential efficacy for the treatment of ...

37

An Overview of Non-drug Therapies for the Treatment of Epilepsy

An Overview of Non-drug Therapies for the Treatment of Epilepsy

... Devices are successful up to some extent only, fewer patients are benefitted and others are still going for other options like radiosurgeries. These surgical methods are useful in patients with focal initiated seizures ...

12

Optimal control of malaria: combining vector interventions and drug therapies

Optimal control of malaria: combining vector interventions and drug therapies

... Drug therapies act to reduce the level of endemicity and suppress the initial spread of disease, while vector con- trol combats disease over time and continuously reduces infection levels towards zero ...

18

The role of drug therapies in the treatment of anorexia and bulimia nervosa: a review of the literature

The role of drug therapies in the treatment of anorexia and bulimia nervosa: a review of the literature

... with 8 patients (five with AN and three with BN). Patients were treated for periods ranging from 4 months to more than 3 years and the drug, used at doses ranging from 5 to 30 mg/day, was well tolerated by all ...

16

The major role of clinicians in the discovery of off label drug therapies

The major role of clinicians in the discovery of off label drug therapies

... In 1992, anesthesiologists published the results of the first use of propofol for the relief of itching due to epidurally administered narcotics. (20) The first author was contacted to determine the events leading up to ...

20

Acceptability of non-drug therapies in older people with orthostatic hypotension: a qualitative study

Acceptability of non-drug therapies in older people with orthostatic hypotension: a qualitative study

... All participants were aged over 60 years and had a clinical diagnosis of OH according to international criteria [1]. To be eligible, the participant’s OH was judged to be second- ary to ageing by their referring ...

8

Advances in the drug therapies of acute myeloid leukemia (except acute promyelocytic leukemia)

Advances in the drug therapies of acute myeloid leukemia (except acute promyelocytic leukemia)

... Abstract: Acute myeloid leukemia (AML) is a heterogeneous hematologic malignancy, characterized by the clonal expansion of myeloid blasts in the peripheral blood, bone marrow, and/or other tissues. The new drugs used for ...

9

Current and novel drug therapies for idiopathic pulmonary fibrosis

Current and novel drug therapies for idiopathic pulmonary fibrosis

... Since then however, there has been an exponential increase in the numbers of subjects enrolling in IPF clinical trials worldwide. At the same time, there has been a quiet evolution in the choice and interpretation of ...

12

Emerging Drug Therapies for Heart Failure

Emerging Drug Therapies for Heart Failure

... The clinical trial named ACTIVE in CHF study (Acute and Chronic Therapeutic Impact of a Vasopressin Antagonist in Congestive Heart Failure) has suggested that tolvaptan admini[r] ...

8

Malaria in pregnancy and drug therapies in Malawi

Malaria in pregnancy and drug therapies in Malawi

... Quinine is an alkaloid derived from the bark of the Cinchona tree. It is still the drug of choice for treatment of severe falciparum malaria in most countries 167 . It is also used as first-line treatment in areas ...

191

Current Possible Drug Therapies for  Ovarian Cancer

Current Possible Drug Therapies for Ovarian Cancer

... The Multicentre Italian Trials in Ovarian Cancer (MITO-7) have launched in Italy, 2008. This randomized, multicenter, open-label, phase 3 trial assessed whether a weekly schedule of carboplatin (AUC 2) plus paclitaxel ...

13

Surrogate endpoints, health outcomes, and the drug-approval process for the treatment of risk factors for cardiovascular disease

Surrogate endpoints, health outcomes, and the drug-approval process for the treatment of risk factors for cardiovascular disease

... The 1962 requirement for adequate and well-controlled studies is currently satisfied by Surrogate end point trials for drug therapies of cardiovascular risk factors Although Sur- rogate [r] ...

5

Newer Nutritional basis in the management of Rheumatoid arthritis

Newer Nutritional basis in the management of Rheumatoid arthritis

... some drug therapies such as Nonsteroidal Anti- Inflammatory Drugs (NSAID’s), prescribed to alleviate rheumatoid arthritis symptoms, may increase the requirements for some nutrients and reduce their ...high ...

6

“CHALLENGES IN ALTERNATIVE INSULIN DELIVERY SYSTEM: A REVIEW” by Salunke H.D*, Ughade P.L, Bare K. R.,
Baviskar D.T, India.

“CHALLENGES IN ALTERNATIVE INSULIN DELIVERY SYSTEM: A REVIEW” by Salunke H.D*, Ughade P.L, Bare K. R., Baviskar D.T, India.

... in drug therapies for Insulin-dependent diabetes mellitus (type I) and for many patients with non-insulin-dependent diabetes mellitus (type ...the drug during formulation ...

6

A nationwide study of the epidemiology of relapsing polychondritis

A nationwide study of the epidemiology of relapsing polychondritis

... Results: We identified 256 patients with RP among cumulatively 11.5 million registered inhabit- ants. We classified these patients into four severity classes as “extremely mild” (n=144), “mild” (n=22), “moderate” (n=41), ...

20

In vitro screening of known drugs identified by scaffold hopping techniques shows promising leishmanicidal activity for suramin and netilmicin

In vitro screening of known drugs identified by scaffold hopping techniques shows promising leishmanicidal activity for suramin and netilmicin

... vitro drug interactions for intracellular ...Possible drug combinations were selected on the basis of their previously determined interactions against promastigotes and their efficacy against intracellular ...

6

A CLINICAL STUDY ON THE ROLE OF NASYA KARMA IN THE MANAGEMENT OF AVABAHUKA (FROZEN SHOULDER) WITH VATADA TAILA .......

A CLINICAL STUDY ON THE ROLE OF NASYA KARMA IN THE MANAGEMENT OF AVABAHUKA (FROZEN SHOULDER) WITH VATADA TAILA .......

... Vatadaa taila has been taken as the trial drug intro- duced through the nostril ethically which is desig- nated as ‘Nasyakarma’ (Pratimarsa nasya or sne- hana nasya). The vatadaa taila (Almond oil) pro- cured from ...

7

INDIAN TRADITIONAL THERAPIES AND BIO PROSPECTING: THEIR ROLE IN DRUG DEVELOPMENT RESEARCH

INDIAN TRADITIONAL THERAPIES AND BIO PROSPECTING: THEIR ROLE IN DRUG DEVELOPMENT RESEARCH

... for drug development research. Indian traditional therapies have been a part of our lifestyle since ...marketed drug formulations at national and international ...

12

Genetic essential tremor in γ aminobutyric acidA receptor α1 subunit knockout mice

Genetic essential tremor in γ aminobutyric acidA receptor α1 subunit knockout mice

... tent with low responsiveness in patients with essential tremor (20), the augmenta- tion of tremor by diazepam was unexpect- ed. Ethanol has several other targets in the brain that could account for its effects. ...

7

Complementary and alternative medicine for treatment of irritable bowel syndrome

Complementary and alternative medicine for treatment of irritable bowel syndrome

... complementary therapies, alternative medicine, acupuncture, fiber, peppermint oil, herbal, traditional, yoga, massage, meditation, mind, relaxation, probiotic, hypnotherapy, psychotherapy, cognitive therapy, or ...

6

Show all 10000 documents...

Related subjects